SANGAMO THERAPEUTICS, INC. Debt Securities, Available-for-sale, Current
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Debt Securities, Available-for-sale, Current of $76.27 million as of 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2023-08-08
- 2023-06-30: Debt Securities, Available-for-sale, Current $76.27M.
- 2023-03-31: Debt Securities, Available-for-sale, Current $127.15M.
- 2022-12-31: Debt Securities, Available-for-sale, Current $177.19M.
- 2022-09-30: Debt Securities, Available-for-sale, Current $219.00M.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2023-06-30 | $76.27M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $127.15M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $177.19M 10-Q · filed 2023-08-08 |
| 2022-09-30 | $219.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $198.02M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $197.54M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $197.68M 10-K · filed 2023-02-23 |
| 2021-09-30 | $246.46M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $359.77M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $464.11M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $510.09M 10-K · filed 2022-02-24 |
| 2020-09-30 | $389.43M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $197.41M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $272.38M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $282.05M 10-K · filed 2021-02-24 |
| 2019-09-30 | $240.56M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $271.88M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $270.03M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $259.71M 10-K · filed 2020-02-28 |
| 2018-09-30 | $419.27M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $480.04M 10-Q · filed 2018-08-08 |
| 2017-12-31 | $193.48M 10-K · filed 2019-03-01 |